Loading clinical trials...
Loading clinical trials...
A Multicenter, Open-Label, Single-Arm Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Patients With Moderate to Severe Allergic Asthma
Conditions
Interventions
Omalizumab
Locations
12
United States
Peninsula Research Associates
Rolling Hills Estates, California, United States
National Jewish Health
Denver, Colorado, United States
Broward Research Center
Pembroke Pines, Florida, United States
University of Iowa Hospitals & Clinics; Internal Medicine
Iowa City, Iowa, United States
University of Michigan
Ann Arbor, Michigan, United States
Mayo Clinic - Rochester
Rochester, Minnesota, United States
Start Date
November 30, 2020
Primary Completion Date
October 18, 2021
Completion Date
October 18, 2021
Last Updated
March 15, 2022
Lead Sponsor
Genentech, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions